INC.;TEVA BRANDED PHARMACEUTICALS PRODUCTS R and D
发明人:
DALVI, MUKUL,TEE, SEAH, KEE
申请号：
PH12016500619
公开号：
PH12016500619A1
申请日:
2016.04.05
申请国别(地区):
PH
年份:
2016
代理人:
摘要：
This invention provides a dry powder inhaler comprising: a dry powder medicament comprising fluticasone propionate, salmeterol xinafoate and a lactose carrier； wherein, the delivered dose of salmeterol per actuation is less than 50 mg； and wherein the dose provides a baseline-adjusted FEV1 in a patient of more than 150 mL within 30 minutes of receiving the dose. A method of treating a patient includes administering to a patient a dry powder medicament having fluticasone propionate, salmeterol xinafoate and a lactose carrier； wherein, the delivered dose of salmeterol per actuation is less than 50 mg； and wherein the dose provides a baseline-adjusted FEV1in a patient of more than 150 mL within 30 minutes of receiving the dose.
